Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2018 | ECP for cutaneous lymphoma: current landscape & first prospective trial

Robert Knobler • 28 Sep 2018
EORTC CLTF 2018
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases T-Cell Lymphoma
PROMPT

Extracorporeal photopheresis (ECP) is a non-surgical procedure currently indicated for the treatment of graft-versus-host disease; however, retrospective analyses have shown that ECP is a useful therapy for cutaneous T-cell lymphoma (CTCL). Here, Robert Knobler, MD, of the Medical University of Vienna, Vienna, Austria, discusses the utilization and benefits of ECP for CTCL, and highlights the upcoming European Organisation for the Research and Treatment of Cancer (EORTC) prospective study investigating the use of ECP in this indication (PROMPT; NCT03563040). This video was recorded at the EORTC Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.

More from Robert Knobler

1:05
Extracorporeal photopheresis for the treatment of CTCL
Robert Knobler • 15 Oct 2021
0:41
Recent advances in understanding and managing CTCL
Robert Knobler • 15 Oct 2021

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals